Department of Gastroenterology, Dietetics and Internal Diseases, Poznan University of Medical Sciences, 49 Przybyszewskiego Street, 60-355 Poznan, Poland.
Department of Physiology, Poznan University of Medical Sciences, 6 Święcickiego Street, 60-781 Poznan, Poland.
Nutrients. 2021 Jan 26;13(2):373. doi: 10.3390/nu13020373.
The endocannabinoid system (ECS) is an endogenous signaling system formed by specific receptors (cannabinoid type 1 and type 2 (CB and CB)), their endogenous ligands (endocannabinoids), and enzymes involved in their synthesis and degradation. The ECS, centrally and peripherally, is involved in various physiological processes, including regulation of energy balance, promotion of metabolic process, food intake, weight gain, promotion of fat accumulation in adipocytes, and regulation of body homeostasis; thus, its overactivity may be related to obesity. In this review, we try to explain the role of the ECS and the impact of genetic factors on endocannabinoid system modulation in the pathogenesis of obesity, which is a global and civilizational problem affecting the entire world population regardless of age. We also emphasize that the search for potential new targets for health assessment, treatment, and the development of possible therapies in obesity is of great importance.
内源性大麻素系统(ECS)是由特定受体(大麻素 1 型和 2 型(CB1 和 CB2))、其内源性配体(内源性大麻素)以及参与其合成和降解的酶组成的内源性信号系统。ECS 参与各种生理过程,包括能量平衡的调节、促进代谢过程、食物摄入、体重增加、促进脂肪在脂肪细胞中的积累以及身体内稳态的调节;因此,其过度活跃可能与肥胖有关。在这篇综述中,我们试图解释 ECS 的作用以及遗传因素对肥胖症发病机制中内源性大麻素系统调节的影响,肥胖症是一个全球性的文明问题,影响着全世界所有年龄段的人口。我们还强调,寻找潜在的新目标,用于肥胖症的健康评估、治疗和可能疗法的开发具有重要意义。